Bevacizumab in a treat-and-extend regimen for neovascular age related macular degeneration in a resource limited sector.
dc.contributor.advisor | Kruse, Carl-Heinz. | |
dc.contributor.author | Le Roux, Etienne Philip. | |
dc.date.accessioned | 2019-01-31T09:08:32Z | |
dc.date.available | 2019-01-31T09:08:32Z | |
dc.date.created | 2016 | |
dc.date.issued | 2016 | |
dc.description | Master of Medical Science in Ophthalmology. University of KwaZulu-Natal. Durban, 2016. | en_US |
dc.description.abstract | Abstract available in PDF file. | en_US |
dc.identifier.uri | http://hdl.handle.net/10413/16068 | |
dc.language.iso | en_ZA | en_US |
dc.subject.other | Bevacizumab. | en_US |
dc.subject.other | Neovascular age. | en_US |
dc.subject.other | Photodynamic therapy. | en_US |
dc.title | Bevacizumab in a treat-and-extend regimen for neovascular age related macular degeneration in a resource limited sector. | en_US |
dc.type | Thesis | en_US |